6 Results

People

  1. Sanchez Vega
    Sanchez Vega
  2. Al-Ahmadie
    Al-Ahmadie
  3. Berger
    Berger
  4. Hellmann
    Hellmann
  5. Ostrovnaya
    Ostrovnaya
  6. Rosenberg
    Rosenberg
  7. Schultz
    Schultz
  8. Solit
    Solit
  9. Abu-Rustum
    Abu-Rustum
  10. Aghajanian
    Aghajanian

Groups

  1. Computational Oncology Service (6)
  2. Department of Medicine (6)
  3. Epidemiology and Biostatistics (6)
  4. GSK Faculty (6)
  5. Solid Tumor Oncology Division (6)
  6. Human Oncology and Pathogenesis Program (5)
  7. Surgery (5)
  8. Sloan Kettering Institute Postdocs (4)
  9. Biostatistics Service (3)
  10. Genitourinary Oncology Service (3)
  1. "cancer immunotherapy"
  2. "GSK Faculty"
  3. "Computational Oncology Service"
Formats
  1. Journal Article (5)
  2. Editorial (1)
Groups
  1. Computational Oncology Service (6)
  2. Department of Medicine (6)
  3. Epidemiology and Biostatistics (6)
  4. GSK Faculty (6)
  5. Solid Tumor Oncology Division (6)
  6. Human Oncology and Pathogenesis Program (5)

More Groups

People
  1. Francisco Sanchez Vega (3)
  2. Ahmet Zehir (2)
  3. David Solit (2)
  4. Hikmat Al-Ahmadie (2)
  5. Irina Ostrovnaya (2)
  6. Jonathan Rosenberg (2)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2019 (2)
  4. 2018 (1)
  5. 2017 (1)
Publications
  1. Clinical Cancer Research (1)
  2. European Urology (1)
  3. Genome Medicine (1)
  4. JCO Precision Oncology (1)
  5. Journal of Clinical Oncology (1)
  6. Nature (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. American Association for Cancer Research (1)
  3. Biomed Central Ltd (1)
  4. Elsevier Science, Inc. (1)
  5. Nature Publishing Group (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Novel genetic subtypes of urothelial carcinoma with differential outcomes on immune checkpoint blockade
    Journal Article

    Sarfaty, M.; Golkaram, M.; Funt, S. A.; Al-Ahmadie, H.; Kaplan, S.; Song, F.; Regazzi, A.; Makarov, V.; Kuo, F.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Ovarian cancer mutational processes drive site-specific immune evasion
    Journal Article

    Vázquez-García, I.; Uhlitz, F.; Ceglia, N.; Lim, J. L. P.; Wu, M.; Mohibullah, N.; Niyazov, J.; Ruiz, A. E. B.; Boehm, K. M.; Bojilova, V.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • Harmonization of tumor mutational burden quantification and association with response to immune checkpoint blockade in non-small-cell lung cancer
    Journal Article

    Vokes, N. I.; Liu, D.; Ricciuti, B.; Jimenez-Aguilar, E.; Rizvi, H.; Dietlein, F.; He, M. X.; Margolis, C. A.; Elmarakeby, H. A.; Girshman, J.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma
    Editorial

    Ladanyi, M.; Sanchez Vega, F.; Zauderer, M.
    Genome Medicine (2019)

    Fulltext@MSK | Save
  • Effects of co-occurring genomic alterations on outcomes in patients with KRAS-mutant non-small cell lung cancer
    Journal Article

    Arbour, K. C.; Jordan, E.; Kim, H. R.; Dienstag, J.; Yu, H. A.; Sanchez-Vega, F.; Lito, P.; Berger, M.; Solit, D. B.; Hellmann, M.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets
    Journal Article

    Pietzak, E. J.; Bagrodia, A.; Cha, E. K.; Drill, E. N.; Iyer, G.; Isharwal, S.; Ostrovnaya, I.; Baez, P.; Li, Q.; Berger, M. F.; more...
    European Urology (2017)

    Fulltext@MSK | Save